GILD

HOLD

Gilead Sciences, Inc.

Healthcare · Rank #38 · Analyzed Jul 13, 2026

$129.83

Current Price

$159.86

Intrinsic Value

low confidence

Upside/Downside

5.7/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score3.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueLow confidence — see rating

Fair Value Range

Low$63.97

Base (IV)$159.86

High$490.10

Entry Points

Conservative$44.78

Moderate$63.97

Aggressive$111.90

⚠️ Warnings

DCF/EPV diverge 5.5x — earnings power and cash flow disagree; fair value is low-confidence (blended conservatively)

Quality & Moat Breakdown

Return on Equity43.4% → 1.0/1.0

Debt LevelD/E 95 → 0/1.0

Revenue QualityGrowth -0.3%, margin Δ+12.3% +recovery → 0.5/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins31.0% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.